Unlocking SLC6A15 (B0AT2): A Dual-Platform Approach To Accelerate Drug Discovery for Neuropsychiatric Disorders

Journal:
Analytical Chemistry
Published:
Affiliations:
1
Authors:
6
Institutions Authors Share
Sanofi-Aventis Deutschland GmbH, Germany
6.000000
1.00